Dr. Dmitri Victorovich Baklanov, MD

Dr. Baklanov practices at Saint Luke's South Hospital in Overland Park, Kansas, part of BJC Health.

Dr. Baklanov's NPI, 1730260456, was assigned on October 18, 2006. Dr. Baklanov holds Missouri license 2006015209.

Dr. Baklanov's primary practice is Saint Luke's South Hospital, at 12300 Metcalf Avenue, Overland Park, KS 66213 in Johnson County. The practice phone is (913) 317-7000.

Dr. Baklanov's primary practice is Saint Luke's South Hospital in Overland Park, Kansas, part of BJC Health. Dr. Baklanov is also affiliated with Saint Luke's Hospital of Kansas City. The medical group on file is Saint Luke's Medical Group. Dmand AI also links Dr. Baklanov to 2 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baklanov practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Baklanov's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Baklanov's licenses on file in 2 states: Missouri and Kansas.

CMS data shows 1,438 Medicare services from Dr. Baklanov across 18 procedure codes in 2024, for 797 Medicare patients. Medicare paid $86,706 for them.

CMS counts 797 Medicare patients who saw Dr. Baklanov in 2024. The largest group is 65 to 74, with 326 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baklanov's median patient age at 77, with 38% women.

In 2024, Dr. Baklanov wrote 5,087 Medicare Part D claims for 788 patients. 88% of them were for generic drugs. CMS names the drug for 4,848 of them, across 40 drugs with 11 or more claims each, at $624,545 in total drug cost. In 2023, CMS named 4,870 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Baklanov for performance year 2024, reported as part of a group. Dr. Baklanov accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 46 procedures of coronary angioplasty and stenting by Dr. Baklanov, more than 81% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 88 general payments to Dr. Baklanov from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Abbott Laboratories paid the most, $3,123.